| answer text |
<p>The UK National Screening Committee (UK NSC) advises Ministers and the National
Health Service in all four countries about all aspects of screening policy and supports
implementation. It keeps evidence in support of new programmes under review. Where
stakeholder organisations or individuals feel that there is enough evidence published
in peer reviewed journals to consider screening for a condition they can submit a
proposal to the UK NSC. For further information please see the UK NSC’s website:</p><p>
</p><p> </p><p> </p><p><a href="http://www.screening.nhs.uk/policyreview__" target="_blank">http://www.screening.nhs.uk/policyreview</a></p><p>
</p><p> </p><p> </p><p>In 2011, the UK NSC recommended that screening for bowel cancer
using flexible sigmoidoscopy should be piloted as part of the NHS Bowel Cancer Screening
Programme. NHS England and Public Health England are working together to set up screening
centres for Bowel Scope Screening (BSS), with over 30% operational by the end of March
2014. Our commitment is to have BSS rolled out to 60% of screening centres in England
by the end of March 2015, and to all screening centres in England by the end of 2016.</p><p>
</p><p> </p><p> </p><p>In early 2015 the UK Collaborative Trial of Ovarian Cancer
Screening is due to be published and the NELSON study, a randomised controlled lung
cancer screening trial using multi-slice low-dose CT in high risk men and women, is
expected to end in December 2015. Following publication of the results of these two
studies the UK NSC will review its recommendation on screening women for ovarian cancer
and screening current and former smokers for lung cancer.</p><p> </p>
|
|
